Shares of health insurance company Oscar Health (NYSE:OSCR) fell 5% in the afternoon session after Wells Fargo downgraded the stock and slashed its price target. The financial institution lowered its rating on the health insurer to “Underweight” from “Equal Weight” and cut its price target to $10 from $16. This move reflects increasing concerns about…
Wedbush is still bullish on Palantir Technologies Inc. (NASDAQ:PLTR), keeping its Outperform rating and $120 price target, despite recent market turbulence. Analysts are doubling down on Palantir’s position as a leader in the AI race, with its AI-driven products (AIP) playing a major role in its future growth. The company’s gross profit margin of 80.25%…
Two major investment firms upgraded price targets on Monday, ushering in a 4% boost for Tesla (TSLA, Financial) shares. Wedbush increased the Tesla price target to $515, a 15% upside from Friday’s close. The firm also believes that Tesla’s autonomous driving and AI advancements could be a big opportunity, given that the incoming Trump administration…
Tesla (TSLA) stock rocketed higher on Thursday on the back of several positive disclosures from the EV maker in its third quarter report. From a Q3 profit beat and improving margins to an improved growth outlook, cheap EV update, and robotaxi rollout, there’s plenty for analysts to chew on for a company whose shares, even…
Wall Street’s bullishness for Nvidia stock endures even as shares trade at record highs. Analysts are upbeat about the next-gen Blackwell chip and Nvidia’s web of enterprise partnerships. Bank of America and Goldman Sachs are among the banks that have raised price targets in recent weeks. Thanks for signing up! Access your favorite topics in…
Nvidia (NVDA) stock closed at a record high on Monday as Wall Street analysts held firm on their bullish positions on the stock ahead of its earnings report in November. Shares of the leading AI chipmaker rose over 4% to close at $143.71 per share. The move comes as Wall Street analysts reiterate their Buy…
After a steep run-up in GM stock (GM), Bernstein analysts are warning investors to proceed with caution. Lead autos analyst Daniel Roeska wrote in a note Monday morning that while GM shares have jumped over 85% since November of last year, there are several headwinds on the way that could dampen the stock’s run. Bernstein…